MedCity News October 2, 2022
Virginia-based Careviso recently raised $17 million in Series B funds. The company — which is focused on improving transparency and access for diagnostic testing — will use the funds to enhance its platform’s price transparency tool and deploy it in physician offices so it can be used at the point of care.
Legislative changes such as the No Surprises Act and the Centers for Medicare and Medicaid Services’ price transparency rule have promised to improve patients’ understanding of the process of paying for healthcare. But these promises remain mostly unfulfilled — patients in the U.S. still have an incredibly hard time determining what their care costs will be.
Careviso is a Falls Church, Virginia-based company tackling this issue by advancing...
Today's Sponsors
Today's Sponsor